Search

Home > Lung Cancer Considered > ESMO 2023 Highlights: Early Stage NSCLC, SCLC, Thymic Carcinoma
Podcast: Lung Cancer Considered
Episode:

ESMO 2023 Highlights: Early Stage NSCLC, SCLC, Thymic Carcinoma
Category: Science & Medicine
Duration: 00:45:04
Publish Date: 2023-11-01 14:48:34
Description: Part 2 of our podcast coverage on ESMO 2023 includes an in-depth interview with Dr. Jarushka Naidoo on early-stage NSCLC, including updates from CheckMate816, Keynote 671 overall survival results, and Checkmate77T, first perceptions about the data, remaining unanswered questions and how to incorporate to our clinical practice. Further, we discussed exciting data in the 2nd line setting for Small-Cell Lung Cancer and a new potential therapeutic option for thymic carcinoma. Tune in for this thought-provoking, data-driven, and practical episode of Lung Cancer Considered.
Total Play: 0